Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Erttmann

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Zeitschrift Fur Kinderchirurgie : Organ Der Deutschen, Der Schweizerischen Und Der Osterreichischen Gesellschaft Fur Kinderchirurgie = Surgery in Infancy and Childhood|October 1, 1983
[Intracranial metastasis in neuroblastoma]R Erttmann, M Heller, N Veelken, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Conserved cytostatic activity of aclarubicin in a doxorubicin selected Friend leukaemia cell line with multifactorial multidrug resistanceR Erttmann, M Münchmeyer, G Looft, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1988
Pharmacokinetics of doxorubicin in man: dose and schedule dependenceR Erttmann, N Erb, A Steinhoff, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 17, 1975
Intestinal transport of 3H-digitoxin in vitro incompatible with simple diffusionK H Damm, A Grosshauser, R R Erttmann
Experientia|March 15, 1980
Effects of probenecid on plasma/tissue distribution of 14C-benzylpenicillin in ratsH Bergholz, R R Erttmann, K H Damm
Nuklearmedizin. Nuclear Medicine|December 1, 1985
[Scintigraphy with radioiodinated meta-iodobenzylguanidine in the diagnosis of neuroblastoma]H W Müller-Gärtner, R Erttmann, K Helmke
Lancet (London, England)|April 19, 1980
Total aganglionosis of the colon and Ondine's curseM Stern, R Erttmann, H H Hellwege, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Doxorubicin: effect of different schedules on toxicity and anti-tumor efficacyS S Bielack, R Erttmann, K Winkler, et al.
Cancer Treatment and Research|January 1, 1993
Intraarterial chemotherapy for osteosarcoma: does the result really justify the effort?S S Bielack, P Bieling, R Erttmann, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?S S Bielack, R Erttmann, B Kempf-Bielack, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Zeitschrift Fur Kinderchirurgie : Organ Der Deutschen, Der Schweizerischen Und Der Osterreichischen Gesellschaft Fur Kinderchirurgie = Surgery in Infancy and Childhood|October 1, 1983
[Intracranial metastasis in neuroblastoma]R Erttmann, M Heller, N Veelken, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Conserved cytostatic activity of aclarubicin in a doxorubicin selected Friend leukaemia cell line with multifactorial multidrug resistanceR Erttmann, M Münchmeyer, G Looft, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1988
Pharmacokinetics of doxorubicin in man: dose and schedule dependenceR Erttmann, N Erb, A Steinhoff, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 17, 1975
Intestinal transport of 3H-digitoxin in vitro incompatible with simple diffusionK H Damm, A Grosshauser, R R Erttmann
Experientia|March 15, 1980
Effects of probenecid on plasma/tissue distribution of 14C-benzylpenicillin in ratsH Bergholz, R R Erttmann, K H Damm
Nuklearmedizin. Nuclear Medicine|December 1, 1985
[Scintigraphy with radioiodinated meta-iodobenzylguanidine in the diagnosis of neuroblastoma]H W Müller-Gärtner, R Erttmann, K Helmke
Lancet (London, England)|April 19, 1980
Total aganglionosis of the colon and Ondine's curseM Stern, R Erttmann, H H Hellwege, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Doxorubicin: effect of different schedules on toxicity and anti-tumor efficacyS S Bielack, R Erttmann, K Winkler, et al.
Cancer Treatment and Research|January 1, 1993
Intraarterial chemotherapy for osteosarcoma: does the result really justify the effort?S S Bielack, P Bieling, R Erttmann, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?S S Bielack, R Erttmann, B Kempf-Bielack, et al.
Pageof 9